GHRP-2 and GHRP-6 stimulate growth hormone release from pituitary tumor cells through protein kinase C signaling, with GHRP-2 being considerably more potent than GHRP-6.
GHRP-2 more potent than GHRP-6GHRP-2 was considerably more potent at stimulating both phosphatidylinositol hydrolysis and GH secretion from pituitary tumor cells
What the researchers found
GHRP-2 was considerably more potent than GHRP-6 at stimulating GH release through PKC-dependent pathways, and both caused crosstalk with the cAMP pathway in gsp oncogene-expressing tumors.
Why it matters
Understanding how GHRPs work at the cellular signaling level helps optimize their clinical use and explains why GHRP-2 may be more effective than GHRP-6.
How the study worked
Human pituitary somatotropinomas (with and without gsp oncogenes) were cultured and treated with GHRP-2 and GHRP-6. Phosphatidylinositol hydrolysis, cAMP production, and GH secretion were measured. PKC inhibition was used to confirm the signaling pathway.
What this study cannot tell us
Study used human pituitary tumor cells, not normal pituitary tissue. Tumor cells may respond differently than healthy cells. In vitro conditions don't replicate in vivo complexity.
How to read the evidence
Moderate in vitro evidence using human pituitary tumor tissue. Provides mechanistic insight but uses tumor cells rather than normal tissue.
When this study was published
Published in 1996, this is an early mechanistic study on GHRPs. GHRP-2's greater potency has been confirmed in subsequent clinical studies.
The bigger picture
This study advanced understanding of how growth hormone-releasing peptides work at the molecular level, informing the development and clinical application of GH secretagogues.
Questions still open
- Does GHRP-2's greater potency over GHRP-6 translate to better clinical outcomes?
- Could the PKC-cAMP pathway crosstalk be therapeutically exploited?
Common questions
What are GHRP-2 and GHRP-6?
Why does potency matter?
Read the original research
Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
Molecular endocrinology (Baltimore, Md.), 10(4), 432-8
Citation
Adams, E F; Lei, T; Buchfelder, M; Bowers, C Y; Fahlbusch, R. (1996). Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.. Molecular endocrinology (Baltimore, Md.), 10(4), 432-8.